-
11.
公开(公告)号:HUE032813T2
公开(公告)日:2017-11-28
申请号:HUE06848237
申请日:2006-12-28
Applicant: VERTEX PHARMA
Inventor: HURTER PATRICIA , GONG YUCHUAN , YOUNG CHRISTOPHER R , CONNELLY PATRICK , ROWE WILLIAM , COSTACHE ADRIANA , KRAWIEC MARIUSZ , FENG YUSHI , TRUDEAU MARTIN
-
12.
公开(公告)号:PL1993360T3
公开(公告)日:2017-08-31
申请号:PL06848237
申请日:2006-12-28
Applicant: VERTEX PHARMA
Inventor: HURTER PATRICIA , GONG YUCHUAN , YOUNG CHRISTOPHER R , CONNELLY PATRICK , ROWE WILLIAM , COSTACHE ADRIANA , KRAWIEC MARIUSZ , FENG YUSHI , TRUDEAU MARTIN
IPC: C07D215/56 , A61K31/445
-
13.
公开(公告)号:AU2016219571A1
公开(公告)日:2016-09-08
申请号:AU2016219571
申请日:2016-08-23
Applicant: VERTEX PHARMA
Inventor: HURTER PATRICIA , CONNELLY PATRICK , ROWE WILLIAM , YOUNG CHRISTOPHER R , COSTACHE ADRIANA , KRAWIEC MARIUSZ , GONG YUCHUAN , FENG YUSHI , TRUDEAU MARTIN
IPC: A61K31/445
Abstract: The present invention relates to solid state forms of N-[2,4-bis(1,1 -dimethylethyl)-5 hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1), pharmaceutical compositions thereof and methods therewith.
-
14.
公开(公告)号:NZ583848A
公开(公告)日:2012-07-27
申请号:NZ58384808
申请日:2008-09-15
Applicant: VERTEX PHARMA
Inventor: DEMATTEI JOHN , FENG YUSHI , HARRISON CRISTIAN , LOOKER ADAM , MUDUNURI PRAVEEN , ROEPER STEFANIE , ZHANG YUEGANG
Abstract: Disclosed is N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide benzene sulfonate and N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide benzene sulfonate H2O. The compounds are used to treat CFTR-mediated diseases, cystic fibrosis, hereditary emphysema, COPD, dry-eye disease or Sjogren's disease.
-
公开(公告)号:SI3219705T1
公开(公告)日:2020-08-31
申请号:SI200632370
申请日:2006-12-28
Applicant: VERTEX PHARMA
Inventor: HURTER PATRICIA , GONG YUCHUAN , YOUNG CHRISTOPHER R , CONNELLY PATRICK , ROWE WILLIAM , COSTACHE ADRIANA , KRAWIEC MARIUSZ , FENG YUSHI , TRUDEAU MARTIN
IPC: C07D215/00 , A61K31/00
-
公开(公告)号:RS60205B1
公开(公告)日:2020-06-30
申请号:RSP20200487
申请日:2006-12-28
Applicant: VERTEX PHARMA
Inventor: HURTER PATRICIA , GONG YUCHUAN , YOUNG CHRISTOPHER R , CONNELLY PATRICK , ROWE WILLIAM , COSTACHE ADRIANA , KRAWIEC MARIUSZ , FENG YUSHI , TRUDEAU MARTIN
IPC: C07D215/56 , A61K31/445
-
17.
公开(公告)号:ES2624554T3
公开(公告)日:2017-07-14
申请号:ES06848237
申请日:2006-12-28
Applicant: VERTEX PHARMA
Inventor: HURTER PATRICIA , GONG YUCHUAN , YOUNG CHRISTOPHER R , CONNELLY PATRICK , ROWE WILLIAM , COSTACHE ADRIANA , KRAWIEC MARIUSZ , FENG YUSHI , TRUDEAU MARTIN
IPC: C07D215/56 , A61K31/445
Abstract: Una dispersión sólida que comprende N-[2,4-bis(1,11-dimetiletilo)-5-hidroxifenilo]-1,4-dihidro-4-oxoquinolina-3-carboxamida amorfa.
-
18.
公开(公告)号:NZ620027A
公开(公告)日:2015-05-29
申请号:NZ62002708
申请日:2008-09-15
Applicant: VERTEX PHARMA
Inventor: FENG YUSHI , LOOKER ADAM , ZHANG YUEGANG , DEMATTEI JOHN , MUDUNURI PRAVEEN , ROEPER STEFANIE , HARRISON CRISTIAN
Abstract: Disclosed is a compound selected from N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1) 2-methylbutyric acid. Also disclosed is a method of making the crystalline forms, pharmaceutical compositions and kits comprising the crystalline forms and the use of the crystalline forms for the manufacture of a medicament for the for treating or lessening the severity of a disease in a patient, wherein said disease is selected from cystic fibrosis, hereditary emphysema, hereditary hemochromatosis, coagulation-fibrinolysis deficiencies, lipid processing deficiencies, lysosomal storage diseases, neurodegenerative diseases, polyglutamine neurological disorders, spongiform encephalopathies, COPD, dry-eye disease, and Sjogren’s disease .
-
公开(公告)号:AU2013201426A1
公开(公告)日:2013-04-04
申请号:AU2013201426
申请日:2013-03-12
Applicant: VERTEX PHARMA
Inventor: HURTER PATRICIA , ROWE WILLIAM , YOUNG CHRISTOPHER R , COSTACHE ADRIANA , CONNELLY PATRICK , KRAWIEC MARIUSZ , GONG YUCHUAN , TRUDEAU MARTIN , FENG YUSHI
IPC: A61K31/445
Abstract: The present invention relates to solid state forms of N-[2,4-bis(1 ,1-dimethylethyl)-5 hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1), pharmaceutical compositions thereof and methods therewith.
-
20.
公开(公告)号:MX2010002974A
公开(公告)日:2010-07-29
申请号:MX2010002974
申请日:2008-09-15
Applicant: VERTEX PHARMA
Inventor: DEMATTEI JOHN , HARRISON CRISTIAN , FENG YUSHI , LOOKER ADAM , MUDUNURI PRAVEEN , ROEPER STEFANIE , ZHANG YUEGANG
Abstract: Se describen en la presente formas sólidas de N- [2,4-bis (1,1-dimetiletil) -5-hidroxiferxil] -1,4-dihidro-4-oxoquinolin-3-c arboxamida, entre las que se incluyen las formas cristalinas de la misma.
-
-
-
-
-
-
-
-
-